FDA.reportPublic FDA data

24 HR aspirin 162.5 MG Extended Release Oral Capsule

RxCUI
1665356
RxNorm name
24 HR aspirin 162.5 MG Extended Release Oral Capsule
Display name
24 HR aspirin 162.5 MG Extended Release Oral Capsule
Full name
24 HR aspirin 162.5 MG Extended Release Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4c2a1403-3862-1efd-0a91-444989222b37aspirin 162.5 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR aspirin 162.5 MG Extended Release Oral Capsule [SCD] · 24 HR ASA 162.5 MG Extended Release Oral Capsule [SY] · aspirin 162.5 MG 24HR Extended Release Oral Capsule [SY]46These highlights do not include all the information needed to use DURLAZA ™ safely and effectively. See full prescribing information for DURLAZA. DURLAZA (aspirin) Extended Release Capsules, for oral use Initial U.S. Approval:201520150925